Denali Therapeutics (DNLI) News Today $18.66 +0.25 (+1.36%) Closing price 10/26/2026 04:00 PM EasternExtended Trading$17.25 -1.41 (-7.56%) As of 04:57 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Denali Therapeutics Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done Denali Therapeutics (NASDAQ:DNLI) Stock Rating Raised to Hold at Wall Street ZenOctober 24 at 1:15 AM | americanbankingnews.comWall Street Zen Upgrades Denali Therapeutics (NASDAQ:DNLI) to HoldOctober 24 at 1:12 AM | marketbeat.comDenali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026October 22, 2026 | globenewswire.comDenali Therapeutics Inc. (DNLI) - What Are Investment Firms Saying About This Stock?October 22, 2026 | americanbankingnews.comDenali Therapeutics Inc. (DNLI) - What Are Analysts Saying About This Stock?October 22, 2026 | marketbeat.comCan Denali's Brain-Delivery Platform Drive Its Next Phase Of Growth?October 21, 2026 | rttnews.comWedbush Cuts Price Target on Denali Therapeutics to $23 From $27, Keeps Outperform RatingOctober 19, 2026 | marketscreener.comMDenali Therapeutics (NASDAQ:DNLI) & Maze Therapeutics (NASDAQ:MAZE) Financial SurveyOctober 18, 2026 | americanbankingnews.comIs Denali Therapeutics (DNLI) Reasonably Valued On Future Cash Flow?October 10, 2026 | finance.yahoo.comDenali Therapeutics (NASDAQ:DNLI) Downgraded by Wall Street Zen to "Sell"October 10, 2026 | marketbeat.comIs Denali Therapeutics (DNLI) Undervalued As Its Share Price Pullback Tests Fair Value?October 9, 2026 | finance.yahoo.comDenali Therapeutics Inc. (NASDAQ:DNLI) Stock Has Average Target Price of $35.85 According to AnalystsSeptember 27, 2026 | marketbeat.comDenali Therapeutics Inc (DNLI)September 25, 2026 | za.investing.comDenali Therapeutics Inc. (DNLI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeptember 14, 2026 | seekingalpha.comDenali Therapeutics Inc. (DNLI) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference TranscriptSeptember 9, 2026 | seekingalpha.comDenali Therapeutics (NASDAQ:DNLI) Insider Sells $64,881.92 in StockSeptember 4, 2026 | insidertrades.comDenali’s DNL921 Trial: Early Alzheimer’s Safety Data That Could Shape Long-Term UpsideAugust 20, 2026 | tipranks.comDenali Therapeutics: Bullish On Avlayah And Their ProspectsAugust 19, 2026 | seekingalpha.comAlexander Schuth Sells 2,857 Shares of Denali Therapeutics (NASDAQ:DNLI) StockAugust 14, 2026 | insidertrades.comDenali Therapeutics (DNLI) Q2 2026 Earnings Call TranscriptAugust 13, 2026 | finance.yahoo.comDenali Therapeutics: AVLAYAH Converts A Platform Story Into A Commercial OneAugust 13, 2026 | seekingalpha.comDenali Therapeutics (DNLI) Receives a Buy from J.P. MorganAugust 12, 2026 | theglobeandmail.comBaillie Gifford Trims Denali Therapeutics (DNLI) Stake in June ReductionAugust 10, 2026 | gurufocus.comDenali Therapeutics Inc. (DNLI) Q2 2026 Earnings Call TranscriptAugust 7, 2026 | seekingalpha.comDenali Therapeutics Inc. 2026 Q2 - Results - Earnings Call PresentationAugust 7, 2026 | seekingalpha.comDenali Therapeutics Reports Second Quarter 2026 Financial Results and Business HighlightsAugust 6, 2026 | finance.yahoo.comDenali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026July 27, 2026 | globenewswire.comGoldman Sachs Remains a Buy on Denali Therapeutics (DNLI)July 23, 2026 | theglobeandmail.comIs Denali Therapeutics (DNLI) Overvalued After Its FDA Approval?July 23, 2026 | finance.yahoo.comDenali Therapeutics (DNLI) Heads To AAIC, Is The Stock Already Pricey?July 23, 2026 | finance.yahoo.comDenali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic ...July 9, 2026 | markets.businessinsider.comDenali Therapeutics to Give Opening Plenary Address at Alzheimer's Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain BarrierJuly 9, 2026 | globenewswire.comDenali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 MillionJune 18, 2026 | globenewswire.comDenali Therapeutics Inc. (DNLI) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptJune 9, 2026 | seekingalpha.comDenali Therapeutics Inc. (DNLI) Presents at Jefferies Global Healthcare Conference 2026 TranscriptJune 5, 2026 | seekingalpha.comDenali Therapeutics Shareholders Back Board, Auditors, Executive PayJune 4, 2026 | tipranks.comDenali Therapeutics Inc. (DNLI): One of the Top Stock Picks of Jeff BezosJune 1, 2026 | finance.yahoo.comDenali Therapeutics: 'Strong Buy' On AVLAYAH Approval And End Of 2026 FTD-GRN DataMay 27, 2026 | seekingalpha.comDenali Therapeutics Inc. (DNLI) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 12, 2026 | seekingalpha.comNancy Pelosi stock tracker highlights Claude's pharma earnings play: 'Will be interesting to see how this one plays out'May 7, 2026 | msn.comDenali Therapeutics Reports First Quarter 2026 Financial Results and Business HighlightsMay 7, 2026 | globenewswire.comWhy Denali Therapeutics (DNLI) Is Down 8.2% After Takeda Exits DNL593 Collaboration And Returns RightsMay 4, 2026 | finance.yahoo.comDenali: The First Commercial Validation Of The Blood-Brain Barrier PlatformMay 3, 2026 | seekingalpha.comWhat Makes Denali Therapeutics (DNLI) One of the Best Biotech Stocks to Invest inApril 29, 2026 | insidermonkey.comWhen Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in BiotechApril 20, 2026 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI) and Fennec Pharmaceuticals (FENC)April 8, 2026 | theglobeandmail.comTakeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's WhyApril 6, 2026 | benzinga.comDenali Therapeutics Inc.April 5, 2026 | edition.cnn.comDenali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)April 3, 2026 | globenewswire.comDenali solved a major challenge in treating a rare genetic disease. Now, shares are flying.April 1, 2026 | msn.com Denali Therapeutics Media Mentions By Week Denali Therapeutics Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DNLI News Sentiment▼0.030.60▲Average Healthcare News Sentiment Denali Therapeutics News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DNLI Articles This Week▼74▲DNLI Articles Average Week Denali Therapeutics Trends on MarketBeatThis week vs. last weekNew Followers2+100%Searches1-50%Page Views2,104-12% Get Denali Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DNLI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Beam Therapeutics News Today BioMarin Pharmaceutical News Today Madrigal Pharmaceuticals News Today ImmunityBio News Today Vaxcyte News Today Krystal Biotech News Today Kymera Therapeutics News Today Protagonist Therapeutics News Today TG Therapeutics News Today Spyre Therapeutics News Today News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Denali Therapeutics dated 10/24/2026. From Our Partners80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredWould Anthropic IPO Burst the Bubble?The biggest IPO in history is likely just weeks away… Anthropic, the company behind Claude AI, is rumoured ...Crypto 101 Media | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredElon Musk’s Hushed FCC Filing. Dec 8th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Denali Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Denali Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
